There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Yield10 Bioscience Inc (YTEN – Research Report) and Vuzix Corporation (VUZI – Research Report) with bullish sentiments.
Yield10 Bioscience Inc (YTEN)
Maxim Group analyst Anthony Vendetti maintained a Buy rating on Yield10 Bioscience Inc yesterday and set a price target of $3. The company’s shares closed last Monday at $1.05.
“Market close, Yield10 reported 2Q19 results that were better than both our estimates and consensus. The research pipeline remains robust and YTEN continues to focus on the commercialization of C3003 in canola which we expect to generate revenue sometime between 2021-2022. The company continued with its efforts for establishing additional partnerships and management mentioned that due to the continued testing success, it has seen an increase in inbound activity. We expect a cash burn rate of approximately $2M a quarter for 2H19 and the need for the company to raise additional capital by year end.”
According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 5.9% and a 47.9% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Ellex Medical Lasers Limited, Restoration Robotics Inc, and Xtant Medical Holdings.
Yield10 Bioscience Inc has an analyst consensus of Strong Buy, with a price target consensus of $2.50, representing a 108.3% upside. In a report released yesterday, Aegis Capital also maintained a Buy rating on the stock with a $2 price target.
Vuzix Corporation (VUZI)
In a report released yesterday, Nehal Chokshi from Maxim Group maintained a Buy rating on Vuzix Corporation, with a price target of $3.50. The company’s shares closed last Monday at $2.01, close to its 52-week low of $1.77.
“Price reductions on prism-based smart glasses drive disappointing revenue and GM. Our longer-term estimates, valuation and Buy rating are driven by VUZI’s waveguide IP for smart glasses, not prism-based smart glasses. On lower CY19E revenue base, consumer electronics rather than niche enterprises like OM, and higher share count due to structure of recent $20M raise, we reduce our terminal period EPS by ~2x and thus 12-month price target to $3.50, from $8.”
According to TipRanks.com, Chokshi is a 4-star analyst with an average return of 4.1% and a 49.6% success rate. Chokshi covers the Consumer Goods sector, focusing on stocks such as Hewlett Packard Enterprise, Super Micro Computer, and Palo Alto Networks.
Vuzix Corporation has an analyst consensus of Moderate Buy, with a price target consensus of $5.25, representing a 167.9% upside. In a report issued on August 11, Chardan Capital also reiterated a Buy rating on the stock with a $7 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.